Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors
Status:
Completed
Trial end date:
2020-05-14
Target enrollment:
Participant gender:
Summary
This is a phase 1, Open-label, Multiple-ascending Dose Study to Investigate the Safety,
Pharmacokinetics, Pharmacodynamics, and Clinical Activity of IMC-001 in Subjects with
Metastatic or Locally-advanced Solid Tumors